Open links in new tab
  1. Psychedelic and Dissociative Drugs - National Institute on Drug Abuse ...

    Aug 29, 2024 · Learn more about NIDA’s research on the health effects and therapeutic potential of psychedelic and dissociative drugs.

  2. Psychedelic and Dissociative Drugs as Medicines

    Jan 24, 2024 · Two dissociative drugs are currently FDA-approved: ketamine, which is approved as an anesthetic, and its derivative, esketamine, for treatment resistant depression. Scientists are …

  3. Psilocybin (Magic Mushrooms) | National Institute on Drug Abuse

    Jan 24, 2024 · Psilocybin is a chemical in certain types of mushrooms that grow on nearly every continent. The mushrooms have a long history of use in traditional ceremonies. Some people use …

  4. Law enforcement seizures of psilocybin mushrooms rose dramatically ...

    Feb 6, 2024 · Law enforcement seizures of “ magic mushrooms” or “shrooms ” containing the psychoactive component psilocybin increased dramatically in the United States between January …

  5. Created Date 4/15/2005 11:14:59 AM

  6. Created Date 4/15/2005 11:03:44 AM

  7. Mini International Neuropsychiatric Interview | NIDA Data Share

    Feb 25, 2016 · The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short, structured, diagnostic interview, developed jointly by psychiatrists and clinicians in the United States and …

  8. Submitter name: Drew Kiraly Submitter email: [email protected] Manipulations of gut microbiome diversity alter cocaine seeking behavior and striatal gene expression.

  9. I agree that to participate in the Challenge, I must comply with the official eligibility criteria, rules, and requirements and that my participation in this Challenge constitutes my full and unconditional …

  10. Lisa Metsch, Ph.D.

    CTN 0064 has two main components: Component 1 is the baseline assessment for CTN 0064. It will also serve as a long-term follow-up assessment for CTN 0049 for those who consent to participate in …